13 research outputs found
An insulin receptor mutant (Asp707 → Ala), involved in leprechaunism, is processed and transported to the cell surface but unable to bind insulin
We have identified a homozygous mutation near the carboxyl terminus of the insulin receptor (IR) α subunit from a leprechaun patient, changing Asp707 into Ala. Fibroblasts from this patient had no high affinity insulin binding sites. To examine the effect of the mutation on IR properties, the mutant IR was stably expressed in Chinese hamster ovary cells. Western blot analysis and metabolic labeling showed a normal processing of the mutant receptor to α and β subunits. No increase in high affinity insulin binding sites was observed on Chinese hamster ovary cells expressing the mutant receptor, and also, affinity cross-linking of 125I- labeled insulin by disuccinimidyl suberate to these cells failed to label the mutant α subunit. Biotinylation of cell surface proteins by biotin succinimidyl ester resulted in efficient biotinylation of the mutant IR α and β subunits, showing its presence on the cell surface. On solubilization of the mutant insulin receptor in Triton X. 100-containing buffers, 125I- insulin was efficiently cross-linked to the receptor a subunit by disuccinimidyl suberate. These studies demonstrate that Ala707 IR is normally processed and transported to the cell surface and that the mutation distorts the insulin binding site. Detergent restores this site. This is an example of a naturally occurring mutation in the insulin receptor that affects insulin binding without affecting receptor transport and processing. This mutation points to a major contribution of the a subunit carboxyl terminus to insulin binding
Activation of overexpressed receptors for insulin and epidermal growth factor interferes in mitogenic signaling without affecting the activation of p21ras
Activated receptors with a tyrosine kinase activity induce a variety of responses like changes in the differentiation and mitogenic status of cells. These responses are mediated in part by p21ras. Some of these activated receptors induce in certain cell types a pronounced, but transient, increase in Ras-GTP. We have stimulated cells with insulin, epidermal growth factor (EGF), and fetal calf serum (FCS), and the mitogenic response, as reflected by stimulation of [3H]thymidine incorporation, was compared with the magnitude of the transient increase in Ras-GTP levels. Cell lines were used that expressed both physiological and elevated numbers of p21ras and receptors for insulin and EGF, respectively. In all the examined cell lines 9% FCS did not induce a marked increase in Ras-GTP despite its high mitogenic potency. Pronounced increases in Ras-GTP levels were observed in insulin-stimulated CHO cells which overexpress insulin receptors whereas in the parental CHO cells only a small increase is seen. Insulin (1 microM) and FCS (9%) stimulate [3H]thymidine incorporation in parental CHO cells to a similar high level whereas in insulin receptor overexpressing CHO cells the maximum of insulin-stimulated [3H]thymidine incorporation is only 55% of the level reached by 9% FCS. In those cells the maximum is already reached at low (1 nM) insulin concentrations. Remarkably, at higher insulin concentrations stimulation of [3H]thymidine incorporation starts to decrease strongly despite the fact that the magnitude of the transient increase in Ras-GTP and subsequent MAPkinase activation increases. Similarly, when EGF receptors are overexpressed in Rat-1 cells, the mitogenic response is also decreased at higher EGF concentrations.(ABSTRACT TRUNCATED AT 250 WORDS
Epidermal-growth-factor receptors generate Ras.GTP more efficiently than insulin receptors
Activation of the Ras proto-oncogene contributes in general to mitogenic activation of cells. We show here that epidermal growth factor (EGF) stimulates Ras.GTP formation very efficiently in a variety of cell lines expressing endogenous EGF receptors only. Maximal activation of the receptor converts up to 65% of cellular p21ras from the GDP form into the active GTP-bound state. This efficient activation occurs also in cultured primary human fibroblasts. Maximal insulin- induced Ras.GTP formation is less but in cells overexpressing the insulin receptor a similar high response of Ras.GTP formation is observed after insulin stimulation. Not only the efficiency but also the kinetics by which the EGF and insulin receptors stimulate Ras.GTP formation are quite distinct. In the Rat-1-derived cell line, H13IR2000, overexpressing both p21Ha-ras and the insulin receptor, the activated insulin receptor generates approximately 1 mol Ras.GTP/mol activated insulin receptor. The activated EGF receptor amplifies the signal, resulting in the activation of approximately 40 mol p21ras/mol receptor. Moreover, EGF-stimulated generation of Ras.GTP is transient with a maximum after 2 min of hormone stimulation and diminishes to near basal levels within 1 h whereas the insulin-induced Ras.GTP levels are maximal at 5-10 min and decline only slowly to half-maximal in 1 h. Desensitization of the EGF pathway by prolonged EGF stimulation, prevents subsequent stimulation of Ras.GTP formation by newly added EGF but not by insulin. Vice versa, in cells preincubated with insulin for 1 h, EGF stimulates Ras.GTP formation to near maximal values. These observations indicate that desensitization by prolonged hormone incubation does not involve inactivation of common signaling intermediates but rather components, specific for each pathway, like the particular receptors. The rapid down regulation of EGF receptors compared to insulin receptors corroborate this possibility. The observed high potency of EGF receptors to generate Ras.GTP may explain the, in general, stronger mitogenic activity of EGF compared to insulin
The role of ras proteins in insulin signal transduction
Ras-proteins are guanine nucleotide binding proteins, which, in the GTP bound state emit a strong mitogenic signal. In the GDP bound state, the protein appears inactive. We have found that stimulation by insulin of cells expressing elevated levels of insulin receptors results in a rapid conversion of Ras-GDP into Ras-GTP. This process is part of the signalling pathway leading to immediate-early gene expression and a mitogenic response. There seems to be no involvement of Ras-GTP formation in the process of insulin stimulated glucose transport. Though the precise mechanism by which Ras is converted to the GTP bound state remains to be established, a tight correlation exists between receptor autophosphorylation and Ras-GTP formation
Middle-aged overweight male south Asians exhibit a different metabolic adaptation to short-term caloric restriction compared to Caucasians
Host-parasite interactio
Cholesterol-lowering effects of metformin in APOE*3-Leiden.CETP mice, a transgenic model with a human-like lipoprotein profile
Diabetes mellitus: pathophysiological changes and therap
Relation between the insulin receptor number in cells, autophosphorylation and insulin-stimulated Ras.GTP formation
We showed previously that upon insulin stimulation
of an insulin receptor overexpressing cell linme,o st of
the p2lras warsa pidly converted into the GTP bound
state (Burgering, B. M. T., Medema, R. H., Maassen,
J. A., Van de Wetering, M. L., Van der Eb, A. J.,
McCormick, F., and Bos, J. L. (1991) EMBO J. 10,
1103-1109). To determine whether this process also
occurs in cells expressing physiologically relevant
numbers of insulin receptors, insulin stimulated
Ras-GTP formation was quantitated in Chinese hamster
ovary (CH0)-derivecde ll lines expressing varying
numbers of insulin receptors. In the parental CH09
cells, expressing only 5.103 insulin receptors, insulin
stimulation for 3 min increased Ras*GTP levels with
10%.U pon increasing the numbero f insulin receptors
in these cells, Ras-GTP levels increased almost proportionally
until a plateau value of 60% is reached at
high receptor numbers. Thesed ata show that receptor
overexpression is not a prerequisite for insulin-stimulated
Ras-GTP formation. Thye ield of Ras-GTP generated
is 0.2-1.0 mol/mol autophosphorylated insulin
receptor in CH09- and NIH3T3-derived cell linesre, -
spectively. These values argue against signal-amplifying
processes between the insulin receptor and
p2 lras.
To determine whether receptor autophosphorylation
is required for Rase GTP formation, NIH3cTe3ll s overexpressing
insulin receptors were stimulated witah
monoclonal antibody which activates the receptor and
subsequent glucose transport without inducing detectable
autophosphorylation. Also, CHO cells expressing
the mutant Ser’200 receptor, which has markedly impaired
tyrosyl autophosphorylation but is capable of
mediating insulin-stimulated metabolic effects CinH O
cells, were used. In both cases, no Ras. GTP formation
was observed.
Furthermore, Rat- 1-derived cell lines expressing
mutant palras, which is permanently in the active
GTP-bound form, still responded to insulin by increasing
the glucose uptake.
These results support our hypothesis that Ras-GTP
formation is activated by the tyrosyl-phosphorylated
insulin receptor and suggest that an active Ras. GTP
complex does not mediate metabolic signaling